Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

AbbVie ready to defend Humira's IP after Amgen files biosimilar

Amgen has submiited its Humira biosimilar for regulatory review in what it believes is the first challenge to AbbVie's blockbuster biologic in the US.

UK-Japan pact to speed regenerative meds to market

The UK and Japan plan to work together on breaking into each other’s markets with regenerative medicines.

Complementary my dear Watson: biopharma tech firm buys Flow Smart for $5.3m

Watson-Marlow Fluid Technologies has bought Flow Smart for £5.7m ($5.3m) to bolster its biopharma-focused pump and fluid path tech portfolio.

UCL spin-out partners with gene therapy firm on eye drug pipeline

University College London is forming a spin-out gene therapy company to develop large molecule treatments for eye disease.

Bigger in Japan: Biopta CEO predicts preclinical CRO business growth under new owners

Preclinical CRO Biopta will add stem cell programming tech to its offering, expand in Japan and nearly double its workforce under new owner, Reprocell.

Novo Nordisk licenses 'small antibody' tech from Ablynx

Ablynx has licensed its nanobody platform to Novo Nordisk which hopes to discover and develop single-domain antibody fragment drug candidates.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...